Femara (Letrozole)

2 Ratting (S)

Letrozole (INN, trade name Femara), It is an oral non-steroidal aromatase inhibitor. It has been introduced for the treatment of hormonally-responsive breast cancer. It is used to treat breast cancer in women. Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme.t is also used for women who have already had other treatment of cancer. Some of the female hormones that occur naturally in the body are the cause can increase the growth of some breast cancer.

  • Share :
For infertility -the dosage is 2.5mg/ day 2.5 mg/day PO for breast cancer. Geriatric -2.5 mg/day PO for breast cancer. Children -Younger than 9 years: Effective and Safe use has not been established. 9 years and older: Effective and Safe use has not been established; however, 2.5 mg/day PO has been used in males with idiopathic short stature.

Related products